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Abstract: Objective: To evaluate the serum
triglyceride and lipoprotein-cholesterol levels
in subjects with and without luteal phase
defect.
Method: Early follicular and midluteal phase
serum triglycerides, lipoprotein-cholesterol
and progesterone levels were assessed in 19
subjects with and in 73 subjects without luteal
phase defect. The criterion for diagnosis of
luteal phase defect was histological
development of endometrium delayed for
more than 2 days according to the
chronological day. The data were analyzed by
paired and unpaired t tests, Chi-square test
and correlation analysis.
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Results: The early follicular serum
triglyceride and lipoprotein-cholesterol levels
of the two groups were similar (p>0.05). The

Introduction
Luteal phase defect, defined as a clinical situation in
which the development of endometrium is deficient due
to insufficient secretion and/or effect of progesterone
during the luteal phase of repetitive ovulatory cycles, is
encountered in 3.7-44.0% of cases of infertility or
recurrent early pregnancy loss (1,2). Although abnormal
response of endometrium to progesterone is thought to
play a role in the pathogenesis of luteal phase defect, it is
emphasized that the main problem in the majority of the
cases is the insufficient production and/or secretion of
progesterone by the corpus luteum (1-4).
Insufficient synthesis and/or secretion of
progesterone in the luteal phase has been shown to be
the result of granulosa or luteal cell defects, abnormal
follicle stimulating hormone (FSH) secretion in follicular
phase or luteinizing hormone (LH) secretion in the luteal
phase or inappropriate preovulatory peaks of these
hormones (1-4). However, it is also suggested that
abnormalities of the serum level of the precursors of

midluteal serum progesterone levels of the
subjects without luteal phase defect was
significantly higher than those of the patients
with luteal phase defect (p<0.01), and the
midluteal triglyceride and lipoproteincholesterol levels of the two groups were also
similar (p>0.05). The midluteal serum
progesterone levels had no significant
correlation with the serum triglyceride or
lipoprotein-cholesterol levels (p>0.05).
Conclusion:
Serum
triglyceride
or
lipoprotein-cholesterol levels, which were
similar in subjects with and without luteal
phase defect, does not play a significant role
in the ethiopathogenesis of this disease.
Key Words: Lipoprotein-cholesterol, Luteal
Phase Defect, Progesterone, Triglyceride

progesterone could affect the synthesis of progesterone
and lead to luteal phase defect (5-9). Cholesterol is the
main precursor of progesterone produced by the corpus
luteum. Although the main source of cholesterol is known
to be the low density lipoprotein (LDL) in circulation, it
was demonstrated that high density lipoprotein (HDL)
and very low density lipoprotein (VLDL) could also be
used effectively as sources (10-11). It is also well known
that the steroid hormones synthesized in the ovary or
administered as medication can affect lipoprotein
production in the liver (12,13). According to these
findings, it is speculated that insufficient lipoproteincholesterol levels in the circulation can also affect the
steroid hormone production and might cause luteal phase
defect due to the results of interaction between the
metabolisms of progesterone and lipoprotein-cholesterols
(5,9).
This prospective study was designed to evaluate the
correlation between the serum levels of progesterone and
triglyceride or lipoprotein-cholesterol in subjects with and
without luteal phase defect.
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Materials and Methods
A total of 120 subjects who had had spontaneous
ovulation and unexplained infertility diagnosed by clinical,
hormonal and laparoscopic evaluation for whom
intrauterine insemination was planned were included in
the study. While spontaneous follicle development and
ovulation were observed in only 38 of the subjects (SO
group), follicular development was induced by
clomiphene citrate (CC group), by human menopausal
gonadotropin (Gntr group) and by human menopausal
gonadotropin after desensitization with gonadotropin
releasing hormone analog (GnRH group) in 38, 18 and
26 of the subjects, respectively. Following adequate
follicle development, intramuscular 5000 IU human
chorionic gonadotropin (hCG) was used to stimulate
ovulation all patient whose follicle growth was induced by
medical methods.
Transvaginal folliculometric evaluations of all subjects
were performed by using a Toshiba SS-A-250 instrument
with a 5 MHz probe beginning from the second or third
day of every cycle. The disappearance of the dominant
follicle with a dimension of 18 to 24 mm prior to the
occurrence of a hyperechogenic structure in the same
ovary, and the presence of fluid in the posterior cul-desac were considered evidence of ovulation (14). The day
on which these findings were obtained was considered
the ovulation day, and chronological dating of
endometrium was calculated prospectively according to
the ovulation day (14).
The endometrial biopsies of all cases were taken
seven, eight or nine days after ovulation as determined by
ultrasonography. All of the biopsies were evaluated
histologically according to Noyes’ criteria by a consultant
of pathology (15). All subjects whose endometrial
histological development was found to be delayed 2 or
more days according to the chronological day calculated
by the ovulation day, were diagnosed with luteal phase
defect (1-4).
Serum levels of progesterone, triglyceride, total
cholesterol and HDL-cholesterol in all cases were assessed
from the fasting morning venous blood samples taken on
the second day of the menstrual cycle and on the seventh
day of ovulation. Serum levels of progesterone were
determined by the two-sided chemoluminometric
immunoassay method, in which an automated Ciba
Corning chemoluminosense system was used. Enzymatic
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cholesterol lipase-glycerol kinase, enzymatic cholesterol
ester hydrolyze-cholesterol oxidase and magnesiumdextran sulfate HDL precipitation methods were used for
the assessment of serum triglyceride, serum total
cholesterol and HDL-cholesterol levels respectively, all of
which were calculated as mg/dl. The serum LDLcholesterol level was calculated by dividing the serum
triglyceride value by five and the VLDL cholesterol level
was calculated subtracting the HDL-cholesterol and LDLcholesterol values from the total cholesterol value. The
serum hCG level was assessed 11 to14 days after
ovulation and those subjects who were found to be
pregnant were excluded from the study. Ages, weights,
heights, tobacco or alcohol consumption, exercise habits,
medical and obstetric histories and infertility periods
were obtained by interviewing the patients. The body
mass index was calculated by dividing the weight (kg) of
the patient by the square of her height (m).
A total of 28 paients who had an endocrine disease or
a medication intake that could affect the serum
progesterone or lipoprotein-cholesterol levels, whose
cycle was canceled, whose ovulation did not occur or who
became pregnant during the study period were excluded
from the study. Thus, the data of a total of 92 cases
including 28 cases in the SO group, 30 cases in the CC
group, 14 cases in the Gntr group and 20 cases in the
GnRH group, were included in the study. Paired t-test,
unpaired t-test, Chi-square test or correlation analysis
were used for statistical analysis.

Results
Ultrasonographic
folliculometric
follow-up,
assessment of serum midluteal progesterone levels and
histopathological evaluation of endometrial biopsies
revealed that ovulation occurred in all of the 92 cases
included in the study. While 73 (79.3%) of the 92 cases
had normal endometrial development, luteal phase defect
was found in 19 (20.7%) of them, including 5 (17.9%)
of the 28 cases in the SO group, 5 (16.6%) of the 30
cases in the CC group, 3 (21.4%) of the 14 cases in the
Gntr group and 6 (30.0%) of the 20 cases in the GnRH
group.
Characteristics of the 19 cases with luteal phase
defect and 73 cases without luteal phase defect are
shown in Table 1. None of the patient in either group was
found to do exercise or use alcohol regularly, and the two
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Table 1.
Cases with Luteal Phase Defect
(n:19)

Cases without Luteal Phase Defect
(n:73)

27.7 ± 1.3

29.3 ± 1.5

Age (year)
Gravidity (n)

0.84 ± 0.16

0.63 ± 0.18

Parity (n)

0.26 ± 0.14

0.18 ± 0.16

Abortion (n)

0.58 ± 0.21

0.45 ± 0.25

6.4 ± 1.2

7.1 ± 1.4

Infertility Period (year)
Body Weight (kg)

60.7 ± 2.7

62.3 ± 2.9

Body Mass Index (kg/m2)

22.5 ± 0.9

23.8 ± 1.7

Tobacco use (n)

2 (10.5%)

13 (17.8%)

Population characteristics of the 19
cases with luteal phase defect and
73 cases without luteal phase
defect*.

*p>0.05

Table 2.

The mean serum progesterone, triglyceride, total cholesterol, HDL-cholesterol, LDL-cholesterol and VLDL-cholesterol levels of the 19 cases
with luteal phase defect and 73 cases without luteal phase defect obtained in early follicular and midluteal phases of the menstrual cycle.
Cases with Luteal Phase Defect (n:19)

Cases without Luteal Phase Defect (n:73)

Early Follicular Phase

Midluteal Phase

Early Follicular Phase

Midluteal Phase

Triglyceride (mg/dl)

132.4 ± 16.3

139.7 ± 22.1

130.5 ± 12.9

142.3 ± 15.2

Total Cholesterol (mg/dl)

162.4 ± 21.8

173.6 ± 18.1

154.6 ± 15.9

178.1 ± 17.4

VLDL-Cholesterol (mg/dl)

26.5 ± 2.3

28.1 ± 3.2

26.2 ± 1.9

28.5 ± 2.5

LDL-Cholesterol (mg/dl)

104.4 ± 10.3

106.9 ± 13.4

101.1 ± 8.3

107.1 ± 9.7

HDL- Cholesterol (mg/dl)

44.2 ± 5.8

45.6 ± 6.0

48.2 ± 3.4

48.8 ± 3.8

Progesterone (ng/ml)

0.56 ± 0.03

11.4 ± 1.1*

0.61 ± 0.04

27.8 ± 3.2*

*p<0.01

groups were similar with respect to mean age, gravidity,
parity, abortion, period of infertility, body weight, body
mass index and rate of tobacco use, which might affect
serum lipoprotein levels (p>0.05).
The mean serum progesterone, triglyceride, total
cholesterol, HDL-cholesterol, LDL-cholesterol and VLDLcholesterol values obtained in the early follicular phase
(the second day of the menstrual cycle) or midluteal phase
(the seventh day of the luteal phase) of the patients with
or without luteal phase defect are presented in Table 2.
Although the early follicular mean serum progesterone
levels of the two groups were similar (p>0.05), the
midluteal mean serum progesterone level of the patients
with luteal phase defect was significantly lower than that
of the patients without luteal phase defect (p<0.01).
However, neither the early follicular phase nor the

midluteal phase serum triglyceride, total cholesterol,
HDL-cholesterol, LDL-cholesterol and VLDL-cholesterol
levels of the patients with luteal phase defect were
significantly different from those of the patients without
luteal phase defect (p>0.05). Moreover, there was no
significant difference between the early follicular and
midluteal phase serum triglyceride, total cholesterol,
HDL-cholesterol, LDL-cholesterol and VLDL-cholesterol
levels in the two groups (p>0.05). There was no
significant correlation between the midluteal serum
progesterone level and serum triglyceride, total
cholesterol, HDL-cholesterol, LDL-cholesterol or VLDLcholesterol level of the patients with luteal phase defect
or those without luteal phase defect with correlation
coefficients ranging from 0.014 to 0.923 and from
0.017 to 0.026, respectively (p>0.05).
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Discussion
Luteal phase defect is defined as a clinical situation
characterized by deficient endometrial development due
to insufficient effect and/or production of progesterone
during the luteal phase in recurrent ovulatory cycles
(1,2). Luteal phase defect can be seen in 3.7-20.0% of all
infertile patients, in 12.0-44.0% of patients with
unexplained infertility and in 20.0-40.0% of those with
recurrent early pregnancy loss (1-4). It is thought that
blastocyst implantation of cannot occur or the
maintenance of pregnancy in the early period cannot be
achieved as a result of insufficient endometrial
development. The occurrence of low pregnancy rates in
spite of high ovulation rates in induced cycles is also
thought to support this idea (1-4).
The observation of insufficient endometrial
development in patients with normal ovarian function
with sufficient luteal serum progesterone levels is
believed to show that endometrial cell defects or
abnormality of progesterone receptors may play a role in
the pathophysiology of luteal phase defect (1,3).
However, corpus luteum dysfunction with abnormal
synthesis of progesterone has been observed to be the
main problem in the majority of patients with luteal phase
defect (1-4). Significant correlations have been found
between the serum level of progesterone and endometrial
development, which was observed to be delayed in
patients with low serum progesterone levels (1-4). It is
known that insufficient secretion of FSH or LH in the
follicular or luteal phase or defects of granulosa or corpus
luteum cells can cause corpus luteum dysfunction and
decreased progesterone production (1,3). However,
insufficiency of circulatory cholesterol, which is the main
precursor of progesterone, has also been claimed to
affect progesterone production and to result in luteal
phase defect in some cases (5,9).
Corpus luteum cells are able to synthesize cholesterol
de novo. However, as the capacity of this function is
limited, most of the cholesterol used in these cells is
supplied by lipoprotein particles in the circulation
(10,11). Although LDL is the most important source of
cholesterol for corpus luteum cells, HDL and VLDL
particles can also be effectively used as cholesterol
sources (10,11). However, lipoproteins have to bind to
their receptors located on the cell membrane for releasing
their cholesterol content into the luteal cells (10).
Therefore, it is suggested that a sufficient amount of
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cholesterol cannot be supplied and synthesis of
progesterone decreases not only in cases with insufficient
serum lipoprotein level but also in those with low density
of lipoprotein receptors, and these abnormalities may
result in luteal phase defect (5-9). While some clinical
studies showed that the LDL receptor density of the luteal
cells increased to the highest level during the midluteal
period concomitantly with the significant increase in the
production of progesterone. Other experimental studies
have found that progesterone synthesis increased
significantly in vitro with the addition of LDL particles into
the medium of luteal cell cultures (7-9). Significantly
lower serum progesterone levels in the luteal phase were
reported in patients with abetalipoproteinemia, a rare
hereditary disease characterized by complete absence of
all apoprotein-B containing lipoproteins including LDL and
VLDL, which were believed to be necessary for the
transport of cholesterol and the production of
progesterone (5,6). However, although the rate of
spontaneous abortion was very high, successful
pregnancy outcomes have been observed in these patients
(16). This condition may be explained by increased denovo cholesterol synthesis by luteal cells or by using HDL
as a main source of cholesterol (9). Achieving successful
pregnancies in other patients with low luteal phase serum
progesterone levels suggested that serum progesterone
level might be sufficient in local uteroplacental circulation,
although it was found to be low in peripheral circulation
(3).
Insler et al. reported in a clinical study in which the
relation between the serum level of lipoproteins and
luteal phase defect was evaluated, that serum lipoprotein
levels of patients with luteal phase defect were similar to
those of the patients without luteal phase defect and the
incidence of luteal phase defect was not increased in
patients with lower serum lipoprotein levels (17). In a
similar study, Hansen et al. also observed that serum
VLDL-cholesterol, LDL-cholesterol, HDL-cholesterol, total
cholesterol and triglyceride levels of patients with luteal
phase defect were not different from those of patients
without luteal phase defect and reported that no
significant correlation was found between the histological
development of endometrium and the serum levels of
lipoprotein-cholesterol or triglyceride (18).
In this study, although the midluteal mean serum
progesterone levels of 19 patients with luteal phase
defect were found to be significantly lower than those of
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the 73 patients without luteal phase defect, early
follicular phase or midluteal phase mean serum
triglyceride, total cholesterol, HDL-cholesterol, LDLcholesterol and VLDL-cholesterol levels of the two groups
were found to be similar (p>0.05). Moreover, neither the
patients with luteal phase defect nor those without luteal
phase defect had any significant correlation between the
midluteal serum progesterone levels and serum
lipoprotein-cholesterol or triglyceride levels, with very
low correlation coefficients ranging from 0.014 to 0.026
(p>0.05). These results, which are in concordance with
those in the literature, suggest that serum triglyceride or
lipoprotein-cholesterol levels did not affect the production
of progesterone by the corpus luteum. Thus, variation of
the serum levels of these substances, which did not have
any correlation with the serum level of progesterone,
could not be responsible for the abnormal development of
the endometrium and could not play a role in the
pathophysiology of luteal phase defect.
It is known that steroid hormones produced de novo
by the ovary or administered as a medication can affect
lipoprotein production in the liver (10,11). Decreased
serum HDL-cholesterol and increased serum LDLcholesterol levels, which occur due to hypoestrogenemia
during the postmenopausal period and increase the risk
of cardiovascular disease, can be reversed by estrogen
replacement therapy 11. Adding exogenous progesterone
to the replacement therapy decreases HDL-cholesterol
and increased serum LDL-cholesterol levels (11).
However, Carr et al. reported that serum LDL-cholesterol
levels significantly decreased simultaneously with
increased serum progesterone levels in the luteal phase
and there was a significant negative correlation between

these substances during the reproductive period (19). In
this study, although it was determined that midluteal
phase mean serum progesterone levels of cases with
luteal phase defect were significantly lower than those of
patients without luteal phase defect and both groups had
significantly higher midluteal phase mean serum
progesterone levels compared to those obtained in the
early follicular phase, the midluteal phase mean serum
triglyceride and lipoprotein-cholesterol levels of both
groups were similar to those obtained in the early
follicular phase. These results suggested that, in contrast
to the exogenous progesterone intake, increased
endogenous progesterone synthesis within the
physiologic limits did not affect the lipoprotein production
in liver or change the levels of these substances in the
circulation.
The data of this study suggested that the early
follicular and midluteal serum triglyceride or lipoproteincholesterol levels were similar in patients with and
without luteal phase defect and there was no significant
correlation between them and the serum progesterone
levels. Therefore, serum lipoprotein-cholesterol levels
could not be responsible for the insufficient progesterone
synthesis in cases with luteal phase defect and could not
play an important role in the pathophysiology of luteal
phase defect.
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